Quent Capital LLC purchased a new stake in UiPath Inc. (NYSE:PATH – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 3,253 shares of the healthcare company’s stock, valued at approximately $41,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Householder Group Estate & Retirement Specialist LLC purchased a new position in shares of UiPath during the 3rd quarter valued at about $25,000. American International Group Inc. purchased a new position in shares of UiPath during the 2nd quarter valued at about $74,000. SRS Capital Advisors Inc. raised its holdings in shares of UiPath by 110.0% during the 2nd quarter. SRS Capital Advisors Inc. now owns 4,636 shares of the healthcare company’s stock valued at $84,000 after buying an additional 2,428 shares in the last quarter. Geneos Wealth Management Inc. purchased a new position in shares of UiPath during the 1st quarter valued at about $108,000. Finally, Point72 Hong Kong Ltd raised its holdings in shares of UiPath by 28,088.9% during the 2nd quarter. Point72 Hong Kong Ltd now owns 5,074 shares of the healthcare company’s stock valued at $92,000 after buying an additional 5,056 shares in the last quarter. Hedge funds and other institutional investors own 56.40% of the company’s stock.
Insider Transactions at UiPath
In related news, CAO Hitesh Ramani sold 12,000 shares of UiPath stock in a transaction that occurred on Friday, March 17th. The stock was sold at an average price of $17.01, for a total transaction of $204,120.00. Following the sale, the chief accounting officer now directly owns 407,349 shares in the company, valued at $6,929,006.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Ashim Gupta sold 40,000 shares of UiPath stock in a transaction that occurred on Friday, March 17th. The stock was sold at an average price of $16.96, for a total transaction of $678,400.00. Following the sale, the chief financial officer now directly owns 1,319,051 shares in the company, valued at $22,371,104.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Hitesh Ramani sold 12,000 shares of UiPath stock in a transaction that occurred on Friday, March 17th. The shares were sold at an average price of $17.01, for a total value of $204,120.00. Following the sale, the chief accounting officer now owns 407,349 shares in the company, valued at $6,929,006.49. The disclosure for this sale can be found here. In the last three months, insiders have sold 92,000 shares of company stock worth $1,546,920. 31.88% of the stock is currently owned by insiders.
Analyst Ratings Changes
UiPath Trading Up 0.8 %
Shares of PATH stock opened at $16.68 on Friday. UiPath Inc. has a fifty-two week low of $10.40 and a fifty-two week high of $31.88. The business’s 50 day moving average price is $15.52 and its 200-day moving average price is $13.66.
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories
- Get a free copy of the StockNews.com research report on UiPath (PATH)
- The Squeeze Is On For EVGo, Rally To Follow
- Is The Bottom In For RH, Or Is This Just A Stopping Point?
- Dividend King H.B. Fuller Signals Slowing In 2023
- Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
- 3 Companies That Just Started Paying Dividends
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.